The L-valine production strain of Escherichia coli was constructed by rational metabolic engineering and stepwise improvement based on transcriptome analysis and gene knockout simulation of the in silico genome-scale metabolic network. Feedback inhibition of acetohydroxy acid synthase isoenzyme III by L-valine was removed by site-directed mutagenesis, and the native promoter containing the transcriptional attenuator leader regions of the ilvGMEDA and ilvBN operon was replaced with the tac promoter. The ilvA, leuA, and panB genes were deleted to make more precursors available for L-valine biosynthesis. This engineered Val strain harboring a plasmid overexpressing the ilvBN genes produced 1.31 g/liter L-valine. Comparative transcriptome profiling was performed during batch fermentation of the engineered and control strains. Among the down-regulated genes, the lrp and ygaZH genes, which encode a global regulator Lrp and L-valine exporter, respectively, were overexpressed. Amplification of the lrp, ygaZH, and lrp-ygaZH genes led to the enhanced production of L-valine by 21.6%, 47.1%, and 113%, respectively. Further improvement was achieved by using in silico gene knockout simulation, which identified the aceF, mdh, and pfkA genes as knockout targets. The VAMF strain (Val ⌬aceF ⌬mdh ⌬pfkA) overexpressing the ilvBN, ilvCED, ygaZH, and lrp genes was able to produce 7.55 g/liter L-valine from 20 g/liter glucose in batch culture, resulting in a high yield of 0.378 g of L-valine per gram of glucose. These results suggest that an industrially competitive strain can be efficiently developed by metabolic engineering based on combined rational modification, transcriptome profiling, and systems-level in silico analysis.systems biology ͉ global regulator ͉ exporter ͉ in silico prediction M ost amino acid-producing bacterial strains have been constructed by random mutagenesis. A significant disadvantage of this approach is the possibility that the random distribution of mutations in regions not directly related to amino acid biosynthesis can cause unwanted changes in physiology and growth retardation. Rational metabolic engineering by specific targeted modifications can overcome this disadvantage. The recent development of omics technology, combined with computational analysis, now provides a new avenue for strain improvement (1-4) by providing new information extracted from a large number of data, which is termed ''systems biotechnology'' (5).L-valine, an essential hydrophobic and branched-chain amino acid, is used as a component of cosmetics and pharmaceuticals as well as animal feed additives. L-valine has been produced by employing bacteria belonging to the genera Brevibacterium, Corynebacterium, and Serratia, which have been improved by random mutation and selection (6, 7). A recent report describes the production of L-valine by rationally constructed Corynebacterium glutamicum, in which a feedback inhibition-resistant small subunit of acetohydroxy acid synthase (AHAS; encoded by ilvN) was generated by site-directed mutagen...